Andercore | $40,000,000 | (Feb 11, 2026)
Garner Health | $118,000,000 | (Feb 11, 2026)
NATILUS | $28,000,000 | (Feb 11, 2026)
Certified by Founder
Lodge
Immunai
start up
United States
- New York, NY
- 28/10/2021
- Series B
- $215,000,000
Comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes
- Industry Biotechnology Research
- Website https://www.immunai.com/
- LinkedIn https://www.linkedin.com/company/immunai/
tem | $75,000,000 | (Feb 11, 2026)
Entire | $60,000,000 | (Feb 11, 2026)
Lema AI | $24,000,000 | (Feb 11, 2026)
ZeroDrift | $2,000,000 | (Feb 11, 2026)
Force Equals | $2,200,000 | (Feb 11, 2026)
Bretton AI | $75,000,000 | (Feb 11, 2026)
Pelgo | $5,500,000 | (Feb 11, 2026)
Newo.ai | $25,000,000 | (Feb 11, 2026)
Equal Parts | $23,000,000 | (Feb 11, 2026)